Glucose sensing technology has been shown to improve an individual’s glucose metrics including A1C, Time in Range, and Glycemic variability, in addition to supporting person-reported outcomes, i.e. quality of life. However, despite access to this technology since 2019, more than half of people living with diabetes continue to have an A1C above target. While continuous glucose monitoring (CGM) is a powerful tool to support people with diabetes in improving their glycemic metrics, it can be both underutilized; and/or under-actioned-upon in people with access to CGM.
 
Join this interactive session to learn with your colleagues how to apply advancements in glucose sensing technology to improve health outcomes in people affected by diabetes in your community pharmacy. 
 

Sponsored by: Abbott